Skip to content
Search

Latest Stories

Huxley Europe relaunches HuxQ10 Capsules with triple certification

Huxley Europe relaunches HuxQ10 Capsules with triple certification
The relaunch underscores Huxley Europe's commitment to health and welfare, offering specially developed formulas for users with dietary restrictions

"Barcodes are becoming obsolete, so we needed a unique selling point," comments Business Development Manager at Huxley Europe, Richard Wertheimer, celebrating the relaunch of its HuxQ10 capsules.

Now boasting a rare triple certification, HuxQ10 capsules are Halal approved by Halal Trust, Kosher approval by Rabbi Adler, and certification as vegan.


This milestone marks a significant step for the company, making HuxQ10 accessible to a wider audience.

Coenzyme Q10, or Q10, is a naturally occurring vitamin-like substance in the body, playing a crucial role in mitochondrial biogenetics and ATP production, which is vital for cellular energy.

It also acts as a powerful antioxidant, capable of regenerating alpha-tocopherol, the active form of vitamin E.

These properties help protect cells from oxidative damage, which is linked to aging and environmental stress.

Additionally, Q10 supports heart health and blood vessels, and enhances male fertility by improving sperm health and mobility.

HuxQ10 is derived from yeast fermentation, creating a product identical to the naturally occurring molecule.

The capsules are formulated with plant-based ingredients, ensuring they are free from the fourteen most common allergens, and contain no antimicrobial preservatives, gluten, wheat, or alcohol. This makes HuxQ10 suitable for a diverse range of dietary needs.

Dennis Gore, a community pharmacist at Dennis Gore Chemist, praised the product: "HuxQ10 is halal, kosher, and vegan certified, making it ideal for most customers."

The Q10 in HuxQ10 is dissolved in natural vegetable oil, with additional plant-based ingredients ensuring its stability and release within the body.

The proprietary SuperADME technology enhances the absorption and effectiveness of Q10, minimizing nutritional wastage.

Uniquely, HuxQ10's plant-based soft capsule shell is made from seaweed, ensuring ease of swallowing. The 100mg Q10 capsules simplify dosage adherence.

Huxley Europe has also embraced innovation with Buyerdock's on-pack iQRcodes, allowing consumers to access Vegan, Halal, and Kosher certificates, stockist information, and company details in various languages via their smartphones.

The relaunch underscores Huxley Europe's commitment to health and welfare, offering specially developed formulas for users with dietary restrictions.

HuxQ10 is priced at £11.95 for 30 capsules and £54.95 for 150 capsules, and is available through Thyme Marketing, Natural Dispensary, and Blukoo.

More For You

RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less